CClinicalTrials.gg
Status unknownNCT05712525GRIPSUpdated Feb 3, 2023

Gut Recovery In Patients Following Surgery

An observational study in Gastrointestinal Diseases and Ileus, sponsored by G-Tech Corporation. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-03.

Sponsored by G-Tech Corporation · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to determine if the myoelectrical measurements made by the G-Tech Wireless Patch System correlate with clinical markers of postoperative recovery such as passage of flatus/bowel movement, oral tolerance of diet and discharge readiness. Subsequently the data will be studied to establish which information in the signals is important in determining when to feed patients and possibly discharge them..

Read the detailed description

Measure myoelectric signals with the G-Tech WPS and determine if a correlation exists between signal strength and the rate of gastrointestinal recovery following surgery. Determine the relationship between gastrointestinal myoelectrical signal strength and clinical markers of recovery such as passage of flatus/bowel movement, oral tolerance of diet and discharge readiness.

02

Conditions studied

  • Gastrointestinal Diseases
  • Ileus
03

In context

Gastrointestinal Diseases

628 studies on the registry are indexed under Gastrointestinal Diseases; 128 are open to participants now.

This study's planned enrollment of 150 is below the median of 325 across 190 observational studies indexed under Gastrointestinal Diseases.

Browse Gastrointestinal Diseases studies →

Lead sponsor

G-Tech Corporation is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who will undergo a colectomy

Inclusion criteria

  • Willing and able to follow all study requirements
  • Eighteen (18) years of age or older
  • Subject is willing and able to follow all study requirements
  • Subject will undergo a colectomy

Exclusion criteria

Exclusion Criteria:

  • Subject is pregnant or suspects pregnancy
  • Known allergy to medical grade adhesive
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testG-Tech Wireless Patch System (WPS)

    Noninvasive monitoring of myoelectrical signals

06

What researchers measure

Primary outcomes

  1. GI Functional Recovery

    Observe a correlation between signal strength and the rate of gastrointestinal recovery following surgery.

    Time frame: 30 days after surgery

Secondary outcomes

  1. Adverse Events

    Anticipated adverse events through hospitalization; Unanticipated adverse events (UADEs) through hospitalization

    Time frame: 30 days after surgery

07

Study locations

1 of 1 sites recruiting
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05712525
Lead sponsor
G-Tech Corporation
Collaborators
Beth Israel Deaconess Medical Center
Responsible party
Sponsor
First posted
Feb 3, 2023
Start date
Oct 7, 2022
Primary completion
Oct 6, 2023 (estimated)
Completion
Oct 6, 2024 (estimated)
Last update
Feb 3, 2023

Study contacts

Robert C Kirby, BS, MBA
Contact
rob@gtechmedical.com
9497517704
Steve Axelrod, Ph D
Contact
steve.axelrod@gtechhealth.com
6502691479
Kristen Crowell, MD
principal investigator · Beth Israel Deaconess Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion